05:46 AM EDT, 07/22/2025 (MT Newswires) -- Telix Pharmaceuticals ( TLX ) said early Tuesday it expects to report about $204 million for its June quarter unaudited revenue, up 63% year-over-year.

Analysts polled by FactSet expect $204 million, for the next report on Aug. 21.

The company reaffirmed its full-year 2025 revenue guidance of $770 million to $800 million. Analysts polled by FactSet expect $826.3 million.

Shares of the company were up 1.6% in recent premarket activity.